High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

Background The study aimed to detect the serum levels of fibroblast growth factor-21 (FGF-21) in fatty pancreas (FP) patients and to investigate their potential clinical value. Methods We screened patients with FP using transabdominal ultrasound. The anthropometric, biochemical and serum levels of F...

Full description

Bibliographic Details
Main Authors: Fei Han, Ling Yin, Xiaoping Yu, Renyan Xu, Mingxiang Tian, Xinnong Liu, Lu Zhou, Lianghao Hu, Weijuan Gong, Weiming Xiao, Guotao Lu, Guanghuai Yao, Yanbing Ding
Format: Article
Language:English
Published: PeerJ Inc. 2023-04-01
Series:PeerJ
Subjects:
Fatty pancreas
Fibroblast growth factor-21
Prognostic marker
Metabolic diseases
Adipocytokine
Online Access:https://peerj.com/articles/15176.pdf

Internet

https://peerj.com/articles/15176.pdf

Similar Items